文献速递乳腺乳腺X线MRUS

乳腺癌风险升高女性中乳腺MRI阴性后对比增强乳腺摄影病灶的短期随访

Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
PubMed 文献 · Eur J Radiol · 2023-09-16

回顾性单中心研究纳入71例乳腺癌风险升高女性共81个对比增强乳腺摄影(CEM)强化病灶,这些病灶在MRI上无对应发现并接受了短期随访CEM。随访期间诊断2例癌症(2.5%,95%CI 0.3-8.6),6个月时检出1例(81个病灶中1个)。作者认为对MRI隐匿病灶进行随访CEM是审慎的,基于6个月低癌症检出率,一年时进行随访可能合理。

要点

  • MRI阴性后CEM上仍可见的强化病灶,6个月随访癌症检出率低(81个病灶中1个)。
  • 多数MRI隐匿的CEM强化病灶为非肿块强化(73/81,90%),肿块强化仅8个(10%)。
  • 短期随访期间诊断2例癌症(2.5%),分别于6个月和12个月检出。

核心结论

  • 对MRI隐匿的CEM强化病灶进行随访CEM是审慎的;鉴于小样本中6个月癌症检出率低(81个病灶中1个),一年时进行随访可能合理。

研究设计与样本

  • 回顾性单中心研究,纳入2014至2021年间乳腺癌风险升高且CEM重组图像显示BI-RADS 0、3、4不确定强化、随后一个月内MRI无对应发现并接受8个月内短期随访CEM的患者,共71例女性(中位年龄49岁)81个强化CEM病灶。

关键影像表现/征象

  • 81个病灶中位大小0.7 cm,73个(90%)为非肿块强化,8个(10%)为强化肿块。
  • 75个病灶同日靶向超声未发现超声对应发现。

诊断标准与关键数值

  • 短期随访期间诊断2例癌症(2.5%,95%CI 0.3-8.6),一例于6个月诊断(浸润性导管癌),一例于12个月诊断(导管原位癌)。
  • 其余79个病灶在6个月随访CEM和一年乳腺X线摄影随访时为良性。

临床应用与阅片要点

  • 作者认为对MRI隐匿的CEM强化病灶进行随访CEM是审慎的,并可能合理地在一年时进行。
  • 短期随访CEM中位间隔6.2个月。

局限性

  • 本研究为回顾性单中心研究。
  • 研究样本小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the outcome of enhancing lesions detected on contrast-enhanced mammography (CEM) that had no correlate on magnetic resonance imaging (MRI) and underwent short-term follow-up CEM.

METHODS: In this retrospective single-center study, we identified patients with elevated breast cancer risk who had a CEM between 2014 and 2021 showing indeterminate enhancement on recombined images (BI-RADS 0, 3, 4) that had no correlate on subsequent MRI (performed within one month), and therefore underwent short-term follow-up CEM (performed within eight months). Medical records and imaging studies were reviewed to collect data on patient and lesion characteristics, and outcomes. Cancer incidence with 95% confidence interval (CI) was calculated.

RESULTS: This study included 71 women (median age 49 years) with 81 enhancing CEM lesions who underwent short-term follow-up CEM (median 6.2 months) after MRI reported no correlate. Of 81 lesions (median size = 0.7 cm), 73 (90%) were non-mass enhancement and 8 (10%) were enhancing masses. No sonographic correlate was identified for 75 lesions that had a same-day targeted ultrasound. Two cancers (2.5%, 95% CI 0.3-8.6) were diagnosed during the short-term follow-up period, one at 6-months (invasive ductal carcinoma) and one at 12-months (ductal carcinoma in situ). The remaining 79 lesions were benign at 6-month follow-up CEM and at one-year mammographic follow-up.

CONCLUSIONS: Follow-up CEM of MRI-occult lesions is prudent and may be reasonable to perform at one-year given the low incidence of cancer detected at six-months (one of 81) in our small study sample.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Coffey K, Dixon LB, Sevilimedu V, et al. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk. Eur J Radiol. 2023. PMID: 37738835. doi:10.1016/j.ejrad.2023.111097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。